TX Houston의 담도계 암 임상 시험
담도계 암 관련 연구 18개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
피험자 모집 중2상
- Research Site, Houston
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
피험자 모집 중1/2상
- MD Anderson Cancer Center, GI Medical Oncology Dept, Houston
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
피험자 모집 중3상
- Research Site, Houston
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
피험자 모집 중1/2상
- University of Texas MD Anderson Cancer Center ( Site 0316), Houston
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
피험자 모집 중2상
- Research Site, Houston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
피험자 모집 중1상
- Oncology Consultants, Houston
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
피험자 모집 중2상
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
피험자 모집 중1상
- MD Anderson, Houston
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
피험자 모집 중3상
- Research Site, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
피험자 모집 중2상
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
피험자 모집 중2상
- Houston Methodist Hospital Cancer Center, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
다른 도시의 담도계 암 시험
- Boston, MA연구 11개
- Los Angeles, CA연구 11개
- New York City, NY연구 10개
- Nashville, TN연구 9개
- San Antonio, TX연구 8개
- Baltimore, MD연구 8개
- Washington, DC연구 7개
- Arlington, VA연구 7개
- Pittsburgh, PA연구 7개
- Columbus, OH연구 6개
- Madison, WI연구 6개
- Baldwin Park, CA연구 6개
Houston의 다른 연구
- 비소세포폐암연구 145개
- 유방암연구 126개
- 암 (전체)연구 122개
- 전이성 암연구 104개
- 대장직장암연구 103개
- 난소암연구 90개
- 급성 골수성 백혈병연구 86개
- 폐암연구 78개
- 전립선암연구 76개
- 자궁내막암연구 69개
- 췌장암연구 62개
- 흑색종연구 59개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.